Systematic review of the evidence on the epidemiology of herpes zoster: incidence in the general population and specific subpopulations in Spain
- PMID: 30660981
- DOI: 10.1016/j.puhe.2018.10.015
Systematic review of the evidence on the epidemiology of herpes zoster: incidence in the general population and specific subpopulations in Spain
Abstract
Objectives: Herpes zoster (HZ) is an important cause of morbidity around the world, especially among the adult population aged >50 years.
Study design: A systematic review of the literature (up to October 31, 2016) was performed to identify available evidence on incidence of HZ in the general population and in a specific subpopulation in Spain.
Methods: PubMed and Embase databases were searched, combining the following search terms: 'herpes zoster', 'diabetes mellitus (DM)', 'chronic obstructive pulmonary disease (COPD)', 'chronic heart failure', 'mental disorders' and 'immunocompromised'. Supplements for local scientific congresses, non-indexed Spanish journals and official epidemiological reports, potentially HZ related, were also manually searched. The inclusion criteria were the following: English or Spanish publications reporting incidence of HZ in the Spanish general population and/or specific subpopulations. No restrictions were applied on the study design or population age.
Results: Among 269 references retrieved (48 PubMed, 148 Embase and 73 manual searching), 34 were finally included. Incidence of HZ in the general population ranged from 2.1 to 5.5/1000 person-years. HZ incidence ranged from 9.4 to 15.3/1000 patients with DM and from 11.0 to 11.4/1000 population with COPD or cardiovascular disease. In asthmatic patients, 6.9 HZ cases/1000 subjects were reported. The highest HZ incidence (1.3-400.0/1000 person-years) was in immunocompromised persons (10.0/1000 patients with cancer, 12.5/1000 patients with AIDS, from 5.0 to 240.0/1000 transplanted patients and from 6.6 to 27.0/1000 population with rheumatic diseases). Three studies estimated an increased risk of HZ in comparison with general population, for patients with DM (24%), COPD (39%) and COPD receiving inhaled corticosteroids (61%).
Conclusions: The results suggest a high risk of HZ in certain age groups and specific subpopulations. This study could contribute to identify target age populations and at-risk groups if implementation of HZ vaccination programmes in Spain would be considered.
Keywords: Epidemiology; Herpes zoster; Risk conditions; Spain; Systematic review.
Copyright © 2019 GlaxoSmithKline Biologicals SA. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Risk and impact of herpes zoster among COPD patients: a population-based study, 2009-2014.BMC Infect Dis. 2018 May 3;18(1):203. doi: 10.1186/s12879-018-3121-x. BMC Infect Dis. 2018. PMID: 29724175 Free PMC article.
-
Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain).Hum Vaccin Immunother. 2014;10(6):1650-60. doi: 10.4161/hv.28620. Epub 2014 May 7. Hum Vaccin Immunother. 2014. PMID: 24805130 Free PMC article.
-
Prevaccination epidemiology of herpes zoster in Denmark: Quantification of occurrence and risk factors.Vaccine. 2017 Oct 9;35(42):5589-5596. doi: 10.1016/j.vaccine.2017.08.065. Epub 2017 Sep 2. Vaccine. 2017. PMID: 28874322
-
Association Between Diabetes Mellitus and the Risk of Herpes Zoster: A Systematic Review and Meta-analysis.J Clin Endocrinol Metab. 2022 Jan 18;107(2):586-597. doi: 10.1210/clinem/dgab675. J Clin Endocrinol Metab. 2022. PMID: 34536279
-
Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis.PLoS One. 2021 Aug 12;16(8):e0255877. doi: 10.1371/journal.pone.0255877. eCollection 2021. PLoS One. 2021. PMID: 34383851 Free PMC article.
Cited by
-
Efficacy and effectiveness of Herpes zoster vaccination in adults with diabetes mellitus: a systematic review and meta-analysis of clinical trials and observational studies.Acta Diabetol. 2023 Oct;60(10):1343-1349. doi: 10.1007/s00592-023-02127-7. Epub 2023 Jun 20. Acta Diabetol. 2023. PMID: 37340183 Free PMC article.
-
Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study.RMD Open. 2021 Apr;7(1):e001499. doi: 10.1136/rmdopen-2020-001499. RMD Open. 2021. PMID: 33832974 Free PMC article.
-
Pulsed radiofrequency of dorsal root ganglion of upper thoracic segment for herpes zoster neuralgia: Case report.Medicine (Baltimore). 2020 Jun 19;99(25):e20807. doi: 10.1097/MD.0000000000020807. Medicine (Baltimore). 2020. PMID: 32569227 Free PMC article.
-
Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines.Viruses. 2022 Nov 29;14(12):2667. doi: 10.3390/v14122667. Viruses. 2022. PMID: 36560671 Free PMC article. Review.
-
Knowledge and Attitudes Concerning Herpes Zoster among People with COPD: An Interventional Survey Study.Vaccines (Basel). 2022 Mar 10;10(3):420. doi: 10.3390/vaccines10030420. Vaccines (Basel). 2022. PMID: 35335052 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical